A Minnesota state court last week gave a group of Medtronic (NYSE:MDT) shareholders another chance at a lawsuit brought over its $50 billion acquisition of Covidien. In early 2015 Medtronic closed the Covidien deal, consummating in the biggest medical device acquisition ever. Shortly after the deal was announced during the summer of 2014, shareholder Lewis Merenstein sued in Minnesota’s […]
Covidien
Aegea Medical picks up former Cardiokinetix, Concentric Medical CEO Sainz | Personnel Moves – May 14, 2018
Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]
Zimmer Biomet picks ex-Covidien exec Lannum for IR chief | Personnel Moves – March 20, 2018
Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]
Appeals court upholds patent ruling for Smith & Nephew
The U.S. Court of Appeals for the Federal Circuit this week upheld a Smith & Nephew (NYSE:SNN) patent in a spat between the company and Hologic (NSDQ:HOLX). The patent relates to endoscope technology used for the removal of uterine tissue, and is owned by both Smith & Nephew and Medtronic (NYSE:MDT) subsidiary Covidien, according to court documents. The […]
Eximis Surgical raises $5m for minimally-invasive tissue removal tool
Eximis Surgical raised $5.1 million as part of a $10.2 million equity round, according to a form filed with the SEC last week. Nearly 30 investors have contributed to the offering, the Colorado-based company reported. Eximis Surgical is developing a surgical tool called XCor, which is designed for minimally-invasive specimen removal in laparoscopic surgery. The company touted […]
Bard, Covidien settle more than 130 pelvic mesh cases
C.R. Bard (NYSE:BCR) and several subsidiaries of Medtronic (NYSE:MDT) unit Covidien settled more than 130 product liability lawsuits brought over pelvic mesh products. The lawsuits were part of multi-district litigation being overseen in the U.S. District Court for Southern West Virginia. last week and yesterday Judge Joseph Goodwin dismissed 134 of the cases with prejudice “because all […]
Medtronic launches opioid-induced respiratory depression study
Medtronic (NYSE:MDT) said today that it’s starting a large study on the effect of pulse oximetry and capnography in opioid-induced respiratory depression, using its Capnostream device. The 1,650-patient Prodigy study aims to create a tool to score the risk of OIRD in patients being treated with opioids for pain, using Capnostream’s continuous pulse oximetry and capnography monitoring […]
Ethicon goes ahead with Enseal X1 launch
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon is going ahead with the launch of its Enseal X1 instrument, despite an ongoing dispute with its longtime rival in the surgical cutting and sealing market, Medtronic (NYSE:MDT) subsidiary Covidien. “Enseal X1 is the latest example of how Ethicon is advancing technology to give surgeons greater control, access, and accuracy during surgical procedures […]
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Covidien spinout Mallinckrodt plc (NYSE:MNK) said today that it closed the $690 million sale of its nuclear imaging business to IBA Molecular. Mallinckrodt’s nuclear imaging business includes 2 manufacturing facilities and more than 800 employees. The $690 million deal, which was announced in August last year, consists of Mallinckrodt’s portfolio of diagnostic imaging products, including medical isotope […]
Medtronic’s Ev3 wins 2nd appeal in ex-rep’s whistleblower lawsuit
A federal appeals court last week dismissed a whistleblower lawsuit filed by a former sales rep for Medtronic (NYSE:MDT) subsidiary Ev3, ruling that the allegations weren’t strong enough to sustain a False Claims Act suit. Whistleblower Jeffrey D’Agostino in October 2010 filed a qui tam lawsuit alleging that Ev3 violated the FCA by promoting its Onyx hydrogel […]
Medtronic supply chain snafu delays Aussie operations
Hospitals in Australia are reportedly running low on medical supplies such as sutures and staples due to a problem with Medtronic‘s (NYSE:MDT) supply chain system. A health department spokesman told The Mercury that some health providers were experiencing delays, but hospitals can share supplies thanks to Australia’s centralized ordering and surgical operations should be unaffected. Some health providers are on […]